Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phasebio Pharmaceuticals Inc (PHAS)
NASDAQ:PHAS
RESEARCH TOOLSreports
Holding PHAS?
Track your performance easily
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 208.00K | $ 117.00K | $ 158.00K | $ 335.00K | $ 10.34M |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -16.55M | $ -10.99M | $ -42.92M | $ -31.70M | $ -26.82M |
| EBITDA | $ -15.95M | $ -10.39M | $ -42.32M | $ -31.57M | $ -26.24M |
| Net Income Common Stockholders | $ -16.66M | $ -11.14M | $ -43.11M | $ -31.92M | $ -28.68M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 7.80M | $ 18.69M | $ 41.80M | $ 56.36M | $ 64.46M |
| Total Assets | $ 22.17M | $ 38.66M | $ 60.54M | $ 77.72M | $ 100.64M |
| Total Debt | $ 5.37M | $ 6.84M | $ 8.32M | $ 9.78M | $ 11.24M |
| Net Debt | $ -2.43M | $ -11.84M | $ -33.48M | $ -46.57M | $ -53.22M |
| Total Liabilities | $ 139.56M | $ 141.06M | $ 153.57M | $ 128.05M | $ 119.81M |
| Stockholders Equity | $ -117.40M | $ -102.39M | $ -93.03M | $ -50.33M | $ -19.18M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.47M | $ -22.93M | $ -21.65M | $ -6.77M | $ -11.34M |
| Operating Cash Flow | $ -10.41M | $ -22.88M | $ -19.99M | $ -6.13M | $ -11.09M |
| Investing Cash Flow | $ -58.00K | $ -49.00K | $ -1.66M | $ -638.00K | $ -252.00K |
| Financing Cash Flow | $ -415.00K | $ -179.00K | $ 7.09M | $ -1.33M | $ -1.17M |
Phasebio Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.